logo

For the Inventor, By the Inventor

Maromme, France

Jean-Claude Lormeau

This inventor holds 19 USPTO granted patents. Top assignees: Choay, S.a., D.r.o.p.i.c., Sanofi. Active years: 1978-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Claude Lormeau. Retrieved from https://idiyas.com/inventor/jean-claude-lormeau

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19

% Patents Active = 100.0

Average Co-Inventor Count = 3.1

ph-index = 14

Forward Citations = 505(Granted Patents)


Location History:

  • Maromme-la-Maine, FR (1978 - 1989)
  • Maromme, FR (1985 - 1991)

Company Filing History:

goldMedal16 out of 49 
 
Choay, S.a.
 patents
silverMedal1 out of 1 
 
D.r.o.p.i.c.
 patent
bronzeMedal1 out of 1,544 
 
Sanofi
 patents
4. 1 out of 44 
 
Sanofi Sa
 patents

Years Active: 1978-1991

Loading Chart...
19 patents (USPTO):Explore Patents
1. 5034520 - Process for recovering heparinic oligosaccharides with an affinity for (1991-07-23),
2. 5019649 - Method for obtaining biologically active mucopolysaccharides of high (1991-05-28),
3. 4990502 - Low molecular weight heparins of regular structure, their preparation (1991-02-05),
4. 4826827 - Short chained oligosaccharides having biological properties, a process (1989-05-02),
5. 4818816 - Process for the organic synthesis of oligosaccharides and derivatives (1989-04-04),
6. 4804652 - Mucopolysaccharides having biological properties, preparation and (1989-02-14),
7. 4801583 - Oligosaccharides and their biological applications (1989-01-31),
8. 4788307 - Oligosaccharidic fractions devoid or practically devoid of (1988-11-29),
9. 4777161 - Medicaments favoring the properties of blood flow and their use in (1988-10-11),
10. 4774231 - Disaccharides formed by patterns having a glucosamine and uronic acid (1988-09-27),
11. 4692435 - Mucopolysaccharide composition having a regulatory action on (1987-09-08),
12. 4686288 - Process for preparing mucopolysaccharide compositions having high (1987-08-11),
13. 4607025 - Disaccharides having a glucosamine and uronic acid structure, and (1986-08-19),
14. 4500519 - Mucopolysaccharides having biological properties, preparation and method (1985-02-19),
15. 4474770 - Oligosaccharides having anti-Xa activity, pharmaceutical compositions (1984-10-02),

Title: Jean-Claude Lormeau: Innovator in the Field of Biologically Active Mucopolysaccharides

Introduction: Jean-Claude Lormeau, based in Maromme, France, is a notable inventor with a prolific portfolio of 19 patents. His contributions to the field of biochemistry, especially in the area of heparinic oligosaccharides and mucopolysaccharides, have had a significant impact on medical and pharmaceutical research.

Latest Patents: Among Lormeau's latest innovations are two noteworthy patents. The first is titled "Process for recovering heparinic oligosaccharides with an affinity for [specific target]." This invention focuses on the essential composition of the oligosaccharides, which are primarily made up of specific chains. The second patent, "Method for obtaining biologically active mucopolysaccharides of high [specific requirement]," details a process for achieving biologically active mucopolysaccharides through controlled depolymerization of heparin. This method emphasizes the precise selection of products that generate nitrous acid to ensure total consumption at the desired degree of depolymerization.

Career Highlights: Jean-Claude Lormeau has worked with several esteemed companies throughout his career, including Choay, S.A. and Sanofi S.A. His roles in these organizations have allowed him to refine his expertise in biochemistry and innovate groundbreaking processes and products that are used in various applications today.

Collaborations: Throughout his career, Lormeau has collaborated with prominent figures in the field, notably Jean Choay and Maurice Petitou. These collaborations have undoubtedly contributed to the development of his innovative patents, enhancing research and delivery of biologically active compounds.

Conclusion: Jean-Claude Lormeau's contributions to the science of mucopolysaccharides are notable and impactful. His 19 patents reflect a robust commitment to innovation that continues to influence the fields of biochemistry and pharmacology. As research progresses, Lormeau’s work remains a crucial part of the conversation surrounding the development of biologically active compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…